All data are based on the daily closing price as of October 30, 2025
c
Chong Kun Dang Pharmaceutical
185750.KO
57.65 USD
-0.27
-0.47%
Overview
Last close
57.65 usd
Market cap
759.66M usd
52 week high
90.07 usd
52 week low
48.18 usd
Target price
79.06 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.6525
Price/Book Value
1.1884
Enterprise Value
751.12M usd
EV/Revenue
0.6444
EV/EBITDA
9.1641
Key financials
Revenue TTM
1.17B usd
Gross Profit TTM
363.69M usd
EBITDA TTM
78.42M usd
Earnings per Share
N/A usd
Dividend
0.77 usd
Total assets
1.11B usd
Net debt
44.41M usd
About
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.